Verdence Capital Advisors LLC Q2 2022 Filing

Filed August 8, 2022

Portfolio Value

$773.0M

Holdings

509

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (509 positions)

#	Stock	Shares	Value	% Portfolio	Type
501	ARRYARRAY TECHNOLOGIES INC	10,617	$117K	0.02%
502	RMTIROCKWELL MED INC	71,689	$92K	0.01%
503	ATAIATAI LIFE SCIENCES NV	19,109	$70K	0.01%
504	PRHICONIFER HLDGS INC	40,404	$67K	0.01%
505	GNWGENWORTH FINL INC	12,486	$44K	0.01%
506	—ZIVO BIOSCIENCE INC	10,000	$39K	0.01%
507	—ADAMIS PHARMACEUTICALS CORP	58,382	$29K	0.00%
508	—SYNCHRONOSS TECHNOLOGIES INC	15,000	$17K	0.00%
509	—ZIVO BIOSCIENCE INC	10,000	$4K	0.00%

PreviousPage 6 of 6